225 related articles for article (PubMed ID: 12119004)
1. Inhibition of cellular enzymes by equine catechol estrogens in human breast cancer cells: specificity for glutathione S-transferase P1-1.
Yao J; Chang M; Li Y; Pisha E; Liu X; Yao D; Elguindi EC; Blond SY; Bolton JL
Chem Res Toxicol; 2002 Jul; 15(7):935-42. PubMed ID: 12119004
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional consequences of inactivation of human glutathione S-transferase P1-1 mediated by the catechol metabolite of equine estrogens, 4-hydroxyequilenin.
Chang M; Shin YG; van Breemen RB; Blond SY; Bolton JL
Biochemistry; 2001 Apr; 40(15):4811-20. PubMed ID: 11294649
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens.
Chang M; Zhang F; Shen L; Pauss N; Alam I; van Breemen RB; Blond SY; Bolton JL
Chem Res Toxicol; 1998 Jul; 11(7):758-65. PubMed ID: 9671538
[TBL] [Abstract][Full Text] [Related]
4. A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines.
Chen Y; Liu X; Pisha E; Constantinou AI; Hua Y; Shen L; van Breemen RB; Elguindi EC; Blond SY; Zhang F; Bolton JL
Chem Res Toxicol; 2000 May; 13(5):342-50. PubMed ID: 10813650
[TBL] [Abstract][Full Text] [Related]
5. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL
Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
[TBL] [Abstract][Full Text] [Related]
6. Unexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugation.
Peng KW; Chang M; Wang YT; Wang Z; Qin Z; Bolton JL; Thatcher GR
Chem Res Toxicol; 2010 Aug; 23(8):1374-83. PubMed ID: 20540524
[TBL] [Abstract][Full Text] [Related]
7. Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro.
Pisha E; Lui X; Constantinou AI; Bolton JL
Chem Res Toxicol; 2001 Jan; 14(1):82-90. PubMed ID: 11170511
[TBL] [Abstract][Full Text] [Related]
8. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
[TBL] [Abstract][Full Text] [Related]
9. Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens.
Wang Z; Chandrasena ER; Yuan Y; Peng KW; van Breemen RB; Thatcher GR; Bolton JL
Chem Res Toxicol; 2010 Aug; 23(8):1365-73. PubMed ID: 20509668
[TBL] [Abstract][Full Text] [Related]
10. Altered apoptotic response in MCF 10A cells treated with the equine estrogen metabolite, 4-hydroxyequilenin.
Li Y; Yao J; Chang M; Cuendet M; Bolton JL
Toxicol Lett; 2004 Dec; 154(3):225-33. PubMed ID: 15501614
[TBL] [Abstract][Full Text] [Related]
11. Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus.
Wang Z; Wijewickrama GT; Peng KW; Dietz BM; Yuan L; van Breemen RB; Bolton JL; Thatcher GR
J Biol Chem; 2009 Mar; 284(13):8633-42. PubMed ID: 19158089
[TBL] [Abstract][Full Text] [Related]
12. Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha.
Liu X; Yao J; Pisha E; Yang Y; Hua Y; van Breemen RB; Bolton JL
Chem Res Toxicol; 2002 Apr; 15(4):512-9. PubMed ID: 11952337
[TBL] [Abstract][Full Text] [Related]
13. The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone.
Zhang F; Chen Y; Pisha E; Shen L; Xiong Y; van Breemen RB; Bolton JL
Chem Res Toxicol; 1999 Feb; 12(2):204-13. PubMed ID: 10027800
[TBL] [Abstract][Full Text] [Related]
14. The equine estrogen metabolite 4-hydroxyequilenin causes DNA single-strand breaks and oxidation of DNA bases in vitro.
Chen Y; Shen L; Zhang F; Lau SS; van Breemen RB; Nikolic D; Bolton JL
Chem Res Toxicol; 1998 Sep; 11(9):1105-11. PubMed ID: 9760286
[TBL] [Abstract][Full Text] [Related]
15. Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A cells: differential gene expression.
Cuendet M; Liu X; Pisha E; Li Y; Yao J; Yu L; Bolton JL
Mutat Res; 2004 Jun; 550(1-2):109-21. PubMed ID: 15135645
[TBL] [Abstract][Full Text] [Related]
16. Response of human mammary epithelial cells to DNA damage induced by 4-hydroxyequilenin: Lack of p53-mediated G1 arrest.
Cuendet M; Bolton JL
Chem Biol Interact; 2006 Jul; 161(3):271-8. PubMed ID: 16730688
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-dependent biotransformation of the alkylating drug thiotepa and transport of its metabolite monoglutathionylthiotepa in human MCF-7 breast cancer cells.
Cnubben NH; Rommens AJ; Oudshoorn MJ; Van Bladeren PJ
Cancer Res; 1998 Oct; 58(20):4616-23. PubMed ID: 9788613
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1.
Bogaards JJ; Venekamp JC; van Bladeren PJ
Chem Res Toxicol; 1997 Mar; 10(3):310-7. PubMed ID: 9084911
[TBL] [Abstract][Full Text] [Related]
19. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I.
Johansson AS; Ridderström M; Mannervik B
Mol Pharmacol; 2000 Mar; 57(3):619-24. PubMed ID: 10692504
[TBL] [Abstract][Full Text] [Related]
20. Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase.
Keese MA; Böse M; Mülsch A; Schirmer RH; Becker K
Biochem Pharmacol; 1997 Dec; 54(12):1307-13. PubMed ID: 9393673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
